Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  AUTOR ROBERT
 2. Date of Event Requiring Statement (Month/Day/Year)
01/27/2005		 3. Issuer Name and Ticker or Trading Symbol
SLM CORP [SLM]
(Last)
(First)
(Middle)
12061 BLUEMONT WAY		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Executive Vice President
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

RESTON, VA 20190		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 90,607
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)   (1) 05/20/2009 Common Stock 60,000 $ 14.4375 D  
Stock Option (Right to Buy)   (2) 05/26/2009 Common Stock 15,000 $ 13.7291 D  
Stock Option (Right to Buy)   (3) 10/16/2010 Common Stock 75,000 $ 16.1875 D  
Stock Option (Right to Buy)   (4) 01/15/2011 Common Stock 30,000 $ 20.1666 D  
Stock Option (Right to Buy)   (5) 05/10/2011 Common Stock 30,000 $ 21.75 D  
Stock Option (Right to Buy)   (6) 01/24/2012 Common Stock 180,000 $ 28.6666 D  
Stock Option (Right to Buy)   (7) 01/28/2013 Common Stock 75,000 $ 35.2 D  
Stock Option (Right to Buy)   (8) 01/29/2014 Common Stock 20,000 $ 37.87 D  
Stock Option (Right to Buy)   (9) 01/27/2015 Common Stock 30,000 $ 50.75 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
AUTOR ROBERT
12061 BLUEMONT WAY
RESTON, VA 20190		       Executive Vice President  

Signatures

By: Mary F. Eure (POA) 02/07/2005
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The options become exercisable in increments of one-third; one-third becomes exercisable one year from the date of the grant, one-third upon the Company's common stock having a closing price on the New York Stock Exchange of $19.05 and $23.81, respectively, for five trading days, they also become exercisable on the eighth anniversary of the grant (May 20, 2007) subject to terms regarding the reporting person's continued service with the Company.
(2) The options become exercisable in increments of one-third; one-third becomes exercisable one year from the date of the grant, one-third upon the Company's common stock having a closing price on the New York Stock Exchange of $19.05 and $23.81, respectively, for five trading days, they also become exercisable on the eighth anniversary of the grant (May 26, 2007) subject to terms regarding the reporting person's continued service with the Company.
(3) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $19.42, for five trading days, they also become exercisable on the fifth anniversary of the grant (October 16, 2005), but no sooner than one year from the grant date.
(4) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $24.20 for five trading days, they also become exercisable on the fifth anniversary of the grant (January 15, 2006), but not sooner than one year from the grant date.
(5) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $26.09, for five trading days, they also become exercisable on the fifth anniversary of the grant (May 10, 2006), but no sooner than one year from the grant date.
(6) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $34.40 for five trading days, they also become exercisable on the eighth anniversary of the grant (January 24, 2010), but no sooner than one year from the grant date.
(7) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $42.24, for five trading days, they also become exercisable on the eighth anniversary of the grant (January 28, 2011), but no sooner than one year from the grant date.
(8) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $45.44, for five trading days, they also become exercisable on the eighth anniversary of the grant (January 29, 2012), but no sooner than one year from the grant date.
(9) These options become exercisable upon the Company's common stock having a closing price on the New York Stock Exchange of $60.90, for five trading days, they also become exercisable on the eighth anniversary of the grant (January 27, 2013), but no sooner than one year from the grant date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.